Here are relevant reports on : genetic-testing-market
-
Preimplantation Genetic Testing Market by Product & Service (Reagents, Consumables, Instruments, Software), Technology (NGS, PCR, SNP, CGH), Procedure (Screening, Diagnosis), Application (Aneuploidy, HLA Typing), Type of cycle - Global Forecast to 2030
The global preimplantation genetic testing market, valued at US$636.4 million in 2024, stood at US$690.2 million in 2025 and is projected to advance at a resilient CAGR of 10.5% from 2024 to 2030, culminating in a forecasted valuation of US$1,135.0 million by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Animal Genetics Market by Animal (Bovine, Porcine), Products & Services (Genetic Materials, Genetic Testing Services), Technology (PCR, NGS, rDNA, Microarray Technology), End User (Animal Farms, Veterinary Hospitals & Clinics) - Global Forecast to 2029
The global animal genetics market, valued at US$2.76 billion in 2023, stood at US$2.97 billion in 2024 and is projected to advance at a resilient CAGR of 7.1% from 2024 to 2029, culminating in a forecasted valuation of US$4.19 billion by the end of the period. Market growth is largely driven by factors such as the increasing consumption of animal-derived protein, growing global population & rapid urbanization, growing customer awareness, increasing demand for companion animals, focus on superior breeds, and an emphasis on genetic services to prevent genetic diseases & business loss.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Genetic Testing Market by Product (Consumables, Equipment, Software & Services), Technology (NGS, PCR, FISH), Testing Type (Predictive & Presymptomatic, Carrier, Prenatal & Newborn, Preimplantation), Methods (Molecular, Genetic, Biochemical), End User (Hospitals, Clinical Labs) - Global Forecast to 2027
The global Genetic Testing market size is projected to reach USD xx million by 2027 from USD xx million in 2022, at a CAGR of xx% during the forecast period.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Clinical Laboratory Services Market by Specialty (Biochemistry, Endocrinology, Microbiology, Hematology, Cytology, Histopathology, Genetic Testing), Providers (Independent Laboratory, Reference Laboratory, Hospital Laboratory) & Geography - Global Forecast to 2022
The clinical laboratory services market is expected to reach USD 146.41 billion by 2022 from USD 113.4 billion in 2017, at a CAGR of 5.2% during the forecast period. The major players in the market are Mayo Medical Laboratories (US), Laboratory Corporation of America Holdings (US), Quest Diagnostics Incorporated (US), Spectra Laboratories Inc. (US), DaVita Healthcare Partners (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Bio-Reference Laboratories (US), Sonic Healthcare (UK), Cerba HealthCare (France), and among others
- Published: December 2017
- Price: $ 4950
- TOC Available:
-
Esoteric Testing Market by Type (Endocrinology, Oncology, Neurology, Genetic Tests, Autoimmune, Infectious Diseases), Technology (ELISA, CLIA, Flow Cytometry, NGS, RT-PCR, Chromatography, Spectrometry), Specimen (Blood, Urine) - Global Forecast to 2029
The global esoteric testing market, valued at US$29.9 billion in 2023, stood at US$32.2 billion in 2024 and is projected to advance at a resilient CAGR of 8.5% from 2024 to 2029, culminating in a forecasted valuation of US$48.3 billion by the end of the period. Growth in the market is primarily driven by the growing geriatric population, advancements in esoteric tests for personalized medicine, increasing research funding for precision medicine, and increase in drug and alcohol abuse and stringent laws mandating drug and alcohol testing.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Genetic Toxicology Testing Market by Product (Assays, Reagents & Consumables, Services), By Application (Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry) & Region - Global Forecast to 2025
The global genetic toxicology testing market growth is primed to transition from $1.2 billion in 2020 to $2.0 billion by 2025, showcasing a strong CAGR of 10.2%. Growth in this market is primarily driven by increased pharmaceutical research activities, opposition to animal testing, and R&D on early toxicity detection.
- Published: December 2020
- Price: $ 4950
- TOC Available:
-
Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, stood at US$145.53 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$246.66 billion by the end of the period. Factors such as the growing integration of AI and ML to enhance precision diagnostics and medicine development supported by rising collaborations between pharmaceutical and diagnostics companies to improve precision healthcare and the rise in direct-to-consumer testing are driving the growth in the market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Plant Genomics Market by Objective (Extraction, Sequencing, Genotyping, Gene Expression, MAS, and GMO-trait Purity Testing), Type (Molecular Engineering and Genetic Engineering), Trait, Application, and Region - Global Forecast 2025
The Plant Genomics Market is expected to grow from USD 7.3 billion in 2019 to USD 11.7 billion by 2025, at a CAGR of 8.3% during the forecast period. This report includes a study on the marketing and development strategies, along with a study on the product portfolios of the leading companies operating in the plant genomics market. It includes the profiles of leading companies such as Eurofins Scientific (Luxembourg), Illumina, Inc. (US), NRGene (Israel), Neogen Corporation (US), Qiagen (Germany), Agilent Technologies (US), KeyGene (Netherlands), LC Sciences (US), Traitgenetics GmbH (Germany), Novogene Corporation (China), Oxford Nanopore Technologies (UK), Genewiz (US), BGI Genomics (China), Genotypic Technologies (India), and Floragenex (US).
- Published: August 2019
- Price: $ 4950
- TOC Available:
-
Crowdsourced Testing Market by Testing Type (Performance Testing, Functionality Testing, Usability Testing, Localization Testing, and Security Testing), Platform, Organization Size, Deployment Mode, Vertical and Region - Global Forecast to 2027
The global Crowdsourced testing market size is expected to reach USD 2.5 billion by 2027, at a Compound Annual Growth Rate (CAGR) of 9.4 % during the forecast period. The Crowdsourced testing market vendors have implemented various types of organic and inorganic growth strategies, such as new product launches, product upgradations, partnerships and agreements, business expansions, and mergers and acquisitions to strengthen their offerings in the market. The major vendors in the global Crowdsourced testing market include Qualitest (US), Nomura Research Institute, Ltd. (Japan), Infosys Limited (India), Cigniti Technologies (US), EPAM Systems, Inc. (US), Flatworld Solutions Pvt. Ltd. (India), Test Yantra Software Solutions (India), Cobalt Labs Inc. (US), Bugcrowd Inc. (US), Qualitrix (India), Global App Testing (UK), Applause App Quality, Inc. (US), Synack (US), Testbirds (Germany), Rainforest QA, Inc. (US), Digivante Ltd (UK), Testlio Inc. (US), Crowdsprint (Australia), MyCrowd (US), Ubertesters Inc. (US), QA Mentor, Inc. (US), Crowd4Test (India), TestUnity (India), usabitest.com (Nigeria), Stardust testing (Canada), and ImpactQA (US). The study includes an in-depth competitive analysis of these key players in the Crowdsourced testing market with their company profiles, recent developments, and key market strategies.
- Published: March 2022
- Price: $ 4950
- TOC Available:
-
Food Safety Testing For Nutrigenomics and Personalized Nutrition Market By Testing Type (Microbiological Testing, Chemical Testing, Nutritional Testing, Genetic Testing), Technology (PCR, Elisa, Chromatography, Mass Spectrometry), End-User (Food Manufacturers, Research Institutions, Healthcare Providers, Mass Spectrometry), And Region - Global Forecast To 2029
The global food safety testing for nutrigenomics and personalized nutrition market growth is on a trajectory of significant expansion, with an estimated value projected to reach USD XX.X billion by 2029 from the 2024 valuation of USD XX.X billion, displaying a promising Compound Annual Growth Rate (CAGR) of X.X%.
- Published: January 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
